New FDA Covid-19 Policy Supports Vaccines for High-Risk Groups, More Clinical Trials for Others

FDA’s new COVID vaccine rules worry Hawaii health professionals

Hawaii island health professionals are concerned changes to U.S. Food and Drug Administration rules for COVID-19 vaccines could limit their availability for healthy people under 65 who get vaccinated to protect vulnerable family members. The FDA on Tuesday announced the changes, which call for placebo-controlled trials on any vaccines that have been updated to be effective against newly discovered strains of the respiratory virus before they can…

New FDA Covid-19 Policy Supports Vaccines for High-Risk Groups, More Clinical Trials for Others

In calling for more clinical testing of vaccines in younger people and those who face a low risk of severe disease from Covid-19, the FDA said its policy will compel generation of more evidence for these groups. Our roundup of regulatory news includes notable firsts for Alzheimer’s diagnosis and migraine treatment. The post New FDA Covid-19 Policy Supports Vaccines for High-Risk Groups, More Clinical Trials for Others appeared first on MedCity N…

Trump's team cited safety in limiting COVID shots: Patients, health advocates see more risk

Larry Saltzman has blood cancer. He's also a retired doctor, so he knows getting COVID-19 could be dangerous for him—his underlying illness puts him at high risk of serious complications and death. To avoid getting sick, he stays away from large gatherings, and he's comforted knowing healthy people who get boosters protect him by reducing his exposure to the virus.

New FDA Covid-19 Policy Supports Vaccines for High-Risk Groups, More Clinical Trials for Others – RamaOnHealthcare

In calling for more clinical testing of vaccines in younger people and those who face a low risk of severe disease from Covid-19, the FDA said its policy will compel generation of more evidence for these groups. Our roundup of regulatory news includes notable firsts for Alzheimer’s diagnosis and migraine treatment.When Covid-19 vaccines roll out [...]

The FDA Plans to Limit Access to Covid Vaccines. Here’s Why That’s Not All Bad.

(MIT Technology Review) – This week, two new leaders at the US Food and Drug Administration announced plans to limit access to covid vaccines, arguing that there is not much evidence to support the value of annual shots in healthy people. New vaccines will be made available only to the people who are most vulnerable—namely, those over 65 and others with conditions that make them more susceptible to severe disease. Anyone else will have to wait. …

FDA Panel Recommends COVID-19 Boosters Target JN.1 Lineage for Upcoming Season

A U.S. Food and Drug Administration (FDA) advisory pane […] The post FDA Panel Recommends COVID-19 Boosters Target JN.1 Lineage for Upcoming Season first appeared on GeneOnline News. The post FDA Panel Recommends COVID-19 Boosters Target JN.1 Lineage for Upcoming Season appeared first on GeneOnline News.